Loading...
•
Mar 31, 2022
Cencora Q2 2022 Earnings Report
Reported revenue of $57.7 billion, a 17.4 percent increase year-over-year, with GAAP diluted EPS of $2.59 and adjusted diluted EPS of $3.22.
Key Takeaways
AmerisourceBergen reported a strong second quarter with revenue increasing by 17.4% year-over-year to $57.7 billion. GAAP diluted EPS was $2.59, and adjusted diluted EPS increased by 27.3% to $3.22. The company also raised its adjusted diluted EPS guidance for fiscal year 2022 to a range of $10.80 to $11.05.
Revenue increased 17.4 percent year-over-year to $57.7 billion.
GAAP diluted EPS was $2.59, compared to $2.10 in the prior year quarter.
Adjusted diluted EPS increased 27.3 percent to $3.22.
Adjusted diluted EPS guidance raised to $10.80 to $11.05 for fiscal year 2022.
Cencora
Cencora
Forward Guidance
AmerisourceBergen is updating its fiscal year 2022 financial guidance to reflect the stronger than expected performance of several of its businesses. Adjusted Diluted Earnings Per Share to be in the range of $10.80 to $11.05, raised from the previous range of $10.60 to $10.90.
Positive Outlook
- Adjusted Diluted Earnings Per Share to be in the range of $10.80 to $11.05.
- Adjusted operating income to grow at least in the high-teens percent range, up from growth in the high-teens percent range.
- U.S. Healthcare Solutions operating income to be in the range of $2.42 to $2.48 billion, representing growth of 7% to 10%, up from a range of $2.375 to $2.45 billion.
- Contribution from COVID treatment distribution was higher than expected in the second quarter of fiscal 2022.
- Company’s full year expectations from COVID treatment distribution are largely unchanged.